Macrophage migration inhibitory factor: A downregulator of early T cell-dependent IFN-γ responses in Plasmodium chabaudi adami (556 KA)-infected mice

Journal of Immunology

Volumn 186, Issue 11, 2011, Pages 6271-6279

  Malu, Diane Tshikudi ^a   Bélanger, Benoit ^b   Desautels, François ^a   Kelendji, Karine ^a   Dalko, Esther ^a   Sanchez Dardon, Jaime ^a   Leng, Lin ^c   Bucala, Richard ^c   Satoskar, Abhay R ^d   Scorza, Tatiana ^a  

^a UNIVERSITÉ DU QUÉBEC À MONTRÉAL   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12 ANTIBODY; INTERLEUKIN 4; MACROPHAGE MIGRATION INHIBITION FACTOR; STAT6 PROTEIN; TRANSCRIPTION FACTOR GATA 3; TRANSCRIPTION FACTOR T BET; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; CYTOTOXIC T LYMPHOCYTE; FEMALE; IMMUNE RESPONSE; IN VITRO STUDY; LYMPHOCYTE ACTIVATION; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PARASITEMIA; PLASMODIUM CHABAUDI; PLASMODIUM CHABAUDI ADAMI; PLASMODIUM CHABAUDI ADAMI INFECTION; PLASMODIUM CHABAUDI INFECTION; PRIORITY JOURNAL; PROTEIN DEFICIENCY; SIGNAL TRANSDUCTION; TH1 CELL; TH2 CELL; WILD TYPE;

ANIMALS; ANTIBODIES; BLOTTING, WESTERN; CD4-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; DOWN-REGULATION; FEMALE; FLOW CYTOMETRY; HOST-PARASITE INTERACTIONS; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-12; INTERLEUKIN-4; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MALARIA; MALE; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; PARASITEMIA; PLASMODIUM CHABAUDI; TH1 CELLS; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79958076705     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1003355     Document Type: Article

References (58)

1. Bacher, M., C. N. Metz, T. Calandra, K. Mayer, J. Chesney, M. Lohoff, D. Gemsa, T. Donnelly, and R. Bucala. 1996. An essential regulatory role for macrophage migration inhibitory factor in T-cell activation. Proc. Natl. Acad. Sci. USA 93: 7849-7854.
2. Lolis, E., and R. Bucala. 2003. Macrophage migration inhibitory factor. Expert Opin. Ther. Targets 7: 153-164.
3. David, J. R. 1966. Delayed hypersensitivity in vitro: its mediation by cell-free substances formed by lymphoid cell-antigen interaction. Proc. Natl. Acad. Sci. USA 56: 72-77.
4. Bloom, B. R., and B. Bennett. 1966. Mechanism of a reaction in vitro associated with delayed-type hypersensitivity. Science 153: 80-82.
5. Bach, J. P., B. Rinn, B. Meyer, R. Dodel, and M. Bacher. 2008. Role of MIF in inflammation and tumorigenesis. Oncology 75: 127-133.
6. Flaster, H., J. Bernhagen, T. Calandra, and R. Bucala. 2007. The macrophage migration inhibitory factor-glucocorticoid dyad: regulation of inflammation and immunity. Mol. Endocrinol. 21: 1267-1280.
7. Onodera, S., K. Suzuki, T. Matsuno, K. Kaneda, M. Takagi, and J. Nishihira. 1997. Macrophage migration inhibitory factor induces phagocytosis of foreign particles by macrophages in autocrine and paracrine fashion. Immunology 92: 131-137. (Pubitemid 27380892)
8. Roger, T., J. David, M. P. Glauser, and T. Calandra. 2001. MIF regulates innate immune responses through modulation of Toll-like receptor 4. Nature 414: 920-924. (Pubitemid 34024744)
9. Mitchell, R. A., H. Liao, J. Chesney, G. Fingerle-Rowson, J. Baugh, J. David, and R. Bucala. 2002. Macrophage migration inhibitory factor (MIF) sustains macrophage proinflammatory function by inhibiting p53: regulatory role in the innate immune response. Proc. Natl. Acad. Sci. USA 99: 345-350.
10. Cooke, G., M. E. Armstrong, and S. C. Donnelly. 2009. Macrophage migration inhibitory factor (MIF), enzymatic activity and the inflammatory response. Biofactors 35: 165-168.
11. Abe, R., T. Peng, J. Sailors, R. Bucala, and C. N. Metz. 2001. Regulation of the CTL response by macrophage migration inhibitory factor. J. Immunol. 166: 747-753.
12. Kobayashi, M., Y. Nasuhara, A. Kamachi, Y. Tanino, T. Betsuyaku, E. Yamaguchi, J. Nishihira, and M. Nishimura. 2006. Role of macrophage migration inhibitory factor in ovalbumin-induced airway inflammation in rats. Eur. Respir. J. 27: 726-734.
13. Mizue, Y., S. Ghani, L. Leng, C. McDonald, P. Kong, J. Baugh, S. J. Lane, J. Craft, J. Nishihira, S. C. Donnelly, et al. 2005. Role for macrophage migration inhibitory factor in asthma. Proc. Natl. Acad. Sci. USA 102: 14410-14415.
14. Stavitsky, A. B., C. N. Metz, S. Liu, J. Xianli, and R. Bucala. 2003. Blockade of macrophage migration inhibitory factor (MIF) in Schistosoma japonicuminfected mice results in an increased adult worm burden and reduced fecundity. Parasite Immunol. 25: 369-374. (Pubitemid 38019280)
15. Awandare, G. A., Y. Ouma, C. Ouma, T. Were, R. Otieno, C. C. Keller, G. C. Davenport, J. B. Hittner, J. Vulule, R. Ferrell, et al. 2007. Role of monocyte-acquired hemozoin in suppression of macrophage migration inhibitory factor in children with severe malarial anemia. Infect. Immun. 75: 201-210.
16. Clark, I. A., A. C. Budd, L. M. Alleva, and W. B. Cowden. 2006. Human malarial disease: a consequence of inflammatory cytokine release. Malar. J. 5: 85.
17. Clark, I. A., L. M. Alleva, A. C. Budd, and W. B. Cowden. 2008. Understanding the role of inflammatory cytokines in malaria and related diseases. Travel Med. Infect. Dis. 6: 67-81.
18. Martiney, J. A., B. Sherry, C. N. Metz, M. Espinoza, A. S. Ferrer, T. Calandra, H. E. Broxmeyer, and R. Bucala. 2000. Macrophage migration inhibitory factor release by macrophages after ingestion of Plasmodium chabaudi-infected erythrocytes: possible role in the pathogenesis of malarial anemia. Infect. Immun. 68: 2259-2267.
19. Jain, V., S. McClintock, A. C. Nagpal, A. P. Dash, J. K. Stiles, V. Udhayakumar, N. Singh, and N. W. Lucchi. 2009. Macrophage migration inhibitory factor is associated with mortality in cerebral malaria patients in India. BMC Res. Notes 2: 36.
20. Chaisavaneeyakorn, S., J. M. Moore, C. Othoro, J. Otieno, S. C. Chaiyaroj, Y. P. Shi, B. L. Nahlen, A. A. Lal, and V. Udhayakumar. 2002. Immunity to placental malaria, IV: Placental malaria is associated with up-regulation of macrophage migration inhibitory factor in intervillous blood. J. Infect. Dis. 186: 1371-1375.
21. Awandare, G. A., J. B. Hittner, P. G. Kremsner, D. O. Ochiel, C. C. Keller, J. B. Weinberg, I. A. Clark, and D. J. Perkins. 2006. Decreased circulating macrophage migration inhibitory factor (MIF) protein and blood mononuclear cell MIF transcripts in children with Plasmodium falciparum malaria. Clin. Immunol. 119: 219-225.
22. Awandare, G. A., P. G. Kremsner, J. B. Hittner, C. C. Keller, I. A. Clark, J. B. Weinberg, and D. J. Perkins. 2007. Higher production of peripheral blood macrophage migration inhibitory factor in healthy children with a history of mild malaria relative to children with a history of severe malaria. Am. J. Trop. Med. Hyg. 76: 1033-1036.
23. Awandare, G. A., J. J. Martinson, T. Were, C. Ouma, G. C. Davenport, J. M. Ong'echa, W. Wang, L. Leng, R. E. Ferrell, R. Bucala, and D. J. Perkins. 2009. MIF (macrophage migration inhibitory factor) promoter polymorphisms and susceptibility to severe malarial anemia. J. Infect. Dis. 200: 629-637.
24. Parroche, P., F. N. Lauw, N. Goutagny, E. Latz, B. G. Monks, A. Visintin, K. A. Halmen, M. Lamphier, M. Olivier, D. C. Bartholomeu, et al. 2007. Malaria hemozoin is immunologically inert but radically enhances innate responses by presenting malaria DNA to Toll-like receptor 9. Proc. Natl. Acad. Sci. USA 104: 1919-1924.
25. Griffith, J. W., T. Sun, M. T. McIntosh, and R. Bucala. 2009. Pure hemozoin is inflammatory in vivo and activates the NALP3 inflammasome via release of uric acid. J. Immunol. 183: 5208-5220.
26. McDevitt, M. A., J. Xie, G. Shanmugasundaram, J. Griffith, A. Liu, C. McDonald, P. Thuma, V. R. Gordeuk, C. N. Metz, R. Mitchell, et al. 2006. A critical role for the host mediator macrophage migration inhibitory factor in the pathogenesis of malarial anemia. J. Exp. Med. 203: 1185-1196.
27. Taylor-Robinson, A. W., and R. S. Phillips. 1993. Protective CD4+ T-cell lines raised against Plasmodium chabaudi show characteristics of either Th1 or Th2 cells. Parasite Immunol. 15: 301-310.
28. Taylor-Robinson, A. 2010. Regulation of immunity to Plasmodium: implications from mouse models for blood stage malaria vaccine design. Exp. Parasitol. 126: 406-414.
29. De Souza, J. B., K. H. Williamson, T. Otani, and J. H. Playfair. 1997. Early g interferon responses in lethal and nonlethal murine blood-stage malaria. Infect. Immun. 65: 1593-1598.
30. Clark, I. A., N. H. Hunt, G. A. Butcher, and W. B. Cowden. 1987. Inhibition of murine malaria (Plasmodium chabaudi) in vivo by recombinant interferon-γ or tumor necrosis factor, and its enhancement by butylated hydroxyanisole. J. Immunol. 139: 3493-3496.
31. Scorza, T., K. Grubb, M. Cambos, C. Santamaria, D. Tshikudi Malu, and T.W. Spithill. 2008. Vaccination with a Plasmodium chabaudi adami multivalent DNA vaccine cross-protects A/J mice against challenge with P. c. adami DK and virulent Plasmodium chabaudi chabaudi AS parasites. Int. J. Parasitol. 38: 819-827.
32. Bozza, M., A. R. Satoskar, G. Lin, B. Lu, A. A. Humbles, C. Gerard, and J. R. David. 1999. Targeted disruption of migration inhibitory factor gene reveals its critical role in sepsis. J. Exp. Med. 189: 341-346.
33. Helmby, H., M. Kullberg, and M. Troye-Blomberg. 1998. Expansion of IL-3-responsive IL-4-producing non-B non-T cells correlates with anemia and IL-3 production in mice infected with blood-stage Plasmodium chabaudi malaria. Eur. J. Immunol. 28: 2559-2570.
34. Wynn, T. A. 2009. Basophils trump dendritic cells as APCs for TH2 responses. Nat. Immunol. 10: 679-681.
35. Rodríguez-Sosa, M., L. E. Rosas, J. R. David, R. Bojalil, A. R. Satoskar, and L. I. Terrazas. 2003. Macrophage migration inhibitory factor plays a critical role in mediating protection against the helminth parasite Taenia crassiceps. Infect. Immun. 71: 1247-1254.
36. Namazi, M. J., and R. S. Phillips. 2010. Immune responses of NIH mice infected with avirulent and virulent strains of Plasmodium chabaudi adami single and mixed infections. Korean J. Parasitol. 48: 23-33.
37. Mullen, A. C., F. A. High, A. S. Hutchins, H. W. Lee, A. V. Villarino, D. M. Livingston, A. L. Kung, N. Cereb, T. P. Yao, S. Y. Yang, and S. L. Reiner. 2001. Role of T-bet in commitment of TH1 cells before IL-12-dependent selection. Science 292: 1907-1910.
38. Lighvani, A. A., D. M. Frucht, D. Jankovic, H. Yamane, J. Aliberti, B. D. Hissong, B. V. Nguyen, M. Gadina, A. Sher, W. E. Paul, and J. J. O'Shea. 2001. T-bet is rapidly induced by interferon-γ in lymphoid and myeloid cells. Proc. Natl. Acad. Sci. USA 98: 15137-15142.
39. Stevenson, M. M., and E. M. Riley. 2004. Innate immunity to malaria. Nat. Rev. Immunol. 4: 169-180.
40. Taylor-Robinson, A. W. 1995. Regulation of immunity to malaria: valuable lessons learned from murine models. Parasitol. Today (Regul. Ed.) 11: 334-342.
41. van der Heyde, H. C., B. Pepper, J. Batchelder, F. Cigel, and W. P. Weidanz. 1997. The time course of selected malarial infections in cytokine-deficient mice. Exp. Parasitol. 85: 206-213.
42. Stevenson, M. M., and M. F. Tam. 1993. Differential induction of helper T cell subsets during blood-stage Plasmodium chabaudi AS infection in resistant and susceptible mice. Clin. Exp. Immunol. 92: 77-83.
43. Zhong, X. B., L. Leng, A. Beitin, R. Chen, C. McDonald, B. Hsiao, R. D. Jenison, I. Kang, S. H. Park, A. Lee, et al. 2005. Simultaneous detection of microsatellite repeats and SNPs in the macrophage migration inhibitory factor (MIF) gene by thin-film biosensor chips and application to rural field studies. Nucleic Acids Res. 33: e121.
44. Bouharoun-Tayoun, H., and P. Druilhe. 1992. Plasmodium falciparum malaria: evidence for an isotype imbalance which may be responsible for delayed acquisition of protective immunity. Infect. Immun. 60: 1473-1481.
45. Snapper, C. M., C. Peschel, and W. E. Paul. 1988. IFN-γ stimulates IgG2a secretion by murine B cells stimulated with bacterial lipopolysaccharide. J. Immunol. 140: 2121-2127.
46. Roussilhon, C., P. Brasseur, P. Agnamey, J. L. Pérignon, and P. Druilhe. 2010. Understanding human-Plasmodium falciparum immune interactions uncovers the immunological role of worms. PLoS ONE 5: e9309.
47. Rainczuk, A., T. Scorza, P. M. Smooker, and T. W. Spithill. 2003. Induction of specific T-cell responses, opsonizing antibodies, and protection against Plasmodium chabaudi adami infection in mice vaccinated with genomic expression libraries expressed in targeted and secretory DNA vectors. Infect. Immun. 71: 4506-4515.
48. Scorza, T., K. Grubb, P. Smooker, A. Rainczuk, D. Proll, and T. W. Spithill. 2005. Induction of strain-transcending immunity against Plasmodium chabaudi adami malaria with a multiepitope DNA vaccine. Infect. Immun. 73: 2974-2985.
49. Furuta, T., T. Kikuchi, Y. Iwakura, and N. Watanabe. 2006. Protective roles of mast cells and mast cell-derived TNF in murine malaria. J. Immunol. 177: 3294-3302. (Pubitemid 44277849)
50. Furuta, T., S. Imajo-Ohmi, H. Fukuda, S. Kano, K. Miyake, and N. Watanabe. 2008. Mast cell-mediated immune responses through IgE antibody and Toll-like receptor 4 by malarial peroxiredoxin. Eur. J. Immunol. 38: 1341-1350.
51. Iezzi, G., E. Scotet, D. Scheidegger, and A. Lanzavecchia. 1999. The interplay between the duration of TCR and cytokine signaling determines T cell polarization. Eur. J. Immunol. 29: 4092-4101.
52. Reyes, J. L., L. I. Terrazas, B. Espinoza, D. Cruz-Robles, V. Soto, I. Rivera- Montoya, L. Gómez-García, H. Snider, A. R. Satoskar, and M. Rodríguez-Sosa. 2006. Macrophage migration inhibitory factor contributes to host defense against acute Trypanosoma cruzi infection. Infect. Immun. 74: 3170-3179.
53. Terrazas, C. A., I. Juarez, L. I. Terrazas, R. Saavedra, E. A. Calleja, and M. Rodriguez-Sosa. 2010. Toxoplasma gondii: impaired maturation and proinflammatory response of dendritic cells in MIF-deficient mice favors susceptibility to infection. Exp. Parasitol. 126: 348-358.
54. Satoskar, A. R., M. Bozza, M. Rodriguez Sosa, G. Lin, and J. R. David. 2001. Migration-inhibitory factor gene-deficient mice are susceptible to cutaneous Leishmania major infection. Infect. Immun. 69: 906-911.
55. Jüttner, S., J. Bernhagen, C. N. Metz, M. Röllinghoff, R. Bucala, and A. Gessner. 1998. Migration inhibitory factor induces killing of Leishmania major by macrophages: dependence on reactive nitrogen intermediates and endogenous TNF-α. J. Immunol. 161: 2383-2390. (Pubitemid 28397052)
56. Debierre-Grockiego, F., M. A. Campos, N. Azzouz, J. Schmidt, U. Bieker, M. G. Resende, D. S. Mansur, R. Weingart, R. R. Schmidt, D. T. Golenbock, et al. 2007. Activation of TLR2 and TLR4 by glycosylphosphatidylinositols derived from Toxoplasma gondii. J. Immunol. 179: 1129-1137.
57. Ropert, C., B. S. Franklin, and R. T. Gazzinelli. 2008. Role of TLRs/MyD88 in host resistance and pathogenesis during protozoan infection: lessons from malaria. Semin. Immunopathol. 30: 41-51.
58. + T lymphocytes mediates symptoms, but is not required for the immunological control of parasites during rodent malaria. Microbes Infect. 9: 881-890.